The effects of prescription drug cost sharing: a review of the evidence
Grootendorst P (2020). Applied Health Economics and Health Policy, 4(1): 37-44.
Examining how economic incentives and public policy shape drug pricing, insurance coverage, and the provision of pharmacy services across Canada and beyond.
“My work focuses on how economic incentives and public policy shape the pharmaceutical landscape — from drug pricing and insurance to the provision of community pharmacy services.”
Paul Grootendorst is a Professor at the Leslie Dan Faculty of Pharmacy and the School of Public Policy & Governance at the University of Toronto. He also holds an adjunct position in the Department of Economics at McMaster University and is a Faculty Associate at the Canadian Centre for Health Economics.
His research examines the impact of public policy and regulations on the behaviour of actors in the pharmaceutical sector and the attendant effects on drug spending, the quality of health care, and other outcomes. For instance, lower reimbursement prices for generic drugs may lower drug plan spending, but can lead to shortages if prices make production unprofitable.
A recognized expert in the field, Grootendorst has published numerous papers and reports on drug pricing strategies and pharmaceutical economics. His work has directly informed government generic drug reimbursement and procurement policy, and he is frequently called upon for comment in media stories on these topics.
He served as Director of the Division of Social and Administrative Pharmacy in the Leslie Dan Faculty of Pharmacy from 2008 to 2015, and is a past President of the Canadian Health Economics Association.
Examining the impact of generic entry, patent protection, pricing regulations, and reimbursement policies on global drug markets. Research on how lower reimbursement prices affect drug availability and market dynamics.
Primary Research Focus
Econometric modeling of health behaviours and the effectiveness of health insurance programs. Studying pharmacare policies and forms of drug coverage, including coverage targeted on expensive drugs that may be feasible if provinces reject a comprehensive national plan.
Economics of community pharmacies: spending, geographic distribution, pharmacist workforce growth, and wage impacts.
Statistical methods for assessing healthcare program effectiveness using observational data.
Grootendorst uses survey and administrative data to examine the impact of policies on the behaviour of actors in the pharmaceutical sector. His work has informed government generic drug reimbursement and procurement policy. He is a recognized expert in the field and is often called upon for comment in media stories related to pharmaceutical economics.
A curated selection of peer-reviewed research papers in health economics and pharmaceutical policy.
Grootendorst P (2020). Applied Health Economics and Health Policy, 4(1): 37-44.
Grootendorst P, Hollis A, Levine M, Pogge T, Edwards NC (2018). Canadian Journal on Aging, 37(2): 137-149.
Grootendorst P, Marshall JK, Holbrook AM, Dolovich LR, O'Brien BJ, Levy AR (2015). Health Services Research, 40(5): 1297-1317.
Schneeweiss S, Dormuth C, Grootendorst P, Soumerai SB, Maclure M (2014). Health Policy, 5(3): 173-184.
Hart WM, Espinosa C, Rovira J, Grootendorst P (2013). Diabetologia, 40(3): 311-318.
Research methodologies and evidence-based approaches to evaluating pharmacy practice and healthcare delivery systems.
Fundamental economic principles applied to healthcare, with emphasis on cost-effectiveness analysis of pharmaceutical interventions.
Advanced study of healthcare market dynamics, supply and demand in medicine, and the economic evaluation of health systems.
Statistical and econometric methods for analyzing health data, causal inference, and policy evaluation using observational data.
Probability, clinical trial design, regression analysis, and statistical inference methods for health research applications.
New analysis from Professor Paul Grootendorst recommends approaches to generate fast, reliable supply of pandemic vaccines. His research provides evidence-based strategies for strengthening vaccine production infrastructure and supply chain resilience.
A new student exchange program links the Leslie Dan Faculty of Pharmacy and Université Paris Cité's pharmacy school. The Paris-Toronto Faculties of Pharmacy Fund offers students opportunities for international research exchanges aligned with their professional interests.
For academic inquiries, media requests, or potential research collaborations, please reach out via the official university channels.
Phone
+1 (416) 946-3994
Office
Room 606, 144 College Street
Toronto, ON M5S 3M2